Methyl (S)-2-(Boc-amino) -3-[(S) -2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8 PF-07321332 Boceprevir Intermediate
Nbunye azụmaahịa PF-07321332 Ndị mmekọ Paxlovid nwere ogo dị elu.
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino) -3-[(S) -2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0] hexane CAS 943516-54-9
Aha Chemical | Methyl (S)-2- (Boc-amino) -3-[(S) -2-oxo-3-pyrrolidinyl] propanoate |
Ụdị okwu | Methyl (S) -2- ((tert-butoxycarbonyl) amino) -3- ((S) -2-oxopyrrolidin-3-yl) propanoate;(αS,3S) -α- [(tert-Butyloxycarbonyl) aMino] -2-oxo-3-pyrrolidinepropanoic acid Methyl Ester;(S) -Methyl 2- ((tert-butoxycarbonyl) amino) -3- ((S) -2-oxopyrrolidin-3-yl) propanoate. |
Nọmba CAS | 328086-60-8 |
Nọmba CAT | RF-PI317 |
Ọnọdụ Ahịa | Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms |
Usoro ihe omimi | C13H22N2O5 |
Ibu molekụla | 286.33 |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Ọcha ka Gbanyụọ-Ọcha ntụ ntụ |
njirimara A | IR: Yiri ihe ntụaka |
njirimara B | Oge njide: Yiri ihe ntụaka |
Ọnwụ na ihicha | ≤1.0% |
Ihe fọdụrụ na mgbanye | ≤0.20% |
Otu adịghị ọcha | ≤0.50% |
Mgbakọta adịghị ọcha | ≤2.0% |
Ọla dị arọ (Pb) | ≤20ppm |
Ịdị ọcha | ≥98.0% |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ọkara nke PF-07321332 Paxlovid (CAS 2628280-40-8) na Boceprevir (CAS 394730-60-0) |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
Methyl (S) -2- (Boc-amino) -3- [(S) -2-oxo-3-pyrrolidinyl] propanoate (CAS 328086-60-8) bụ etiti nke PF-07321332 Paxlovid (CAS 2628280-40) -8) na Boceprevir (CAS 394730-60-0).PF-07321332, ihe bụ isi akụrụngwa nke Paxlovid (PF-07321332 na Ritonavir) bụ onye nyocha COVID-19 ọnụ na-achọ mgbochi nje, bụ onye na-egbochi ọnụ 3C-dị ka protease (3CLPRO) nwere mmetụta antiviral megide nje SARS-CoV-2. na COVID-19.Na Nọvemba 6th 2021, Pfizer kwupụtara na Paxlovid belatara ụlọ ọgwụ na ọnwụ nke ukwuu, dabere na nyocha nwa oge nke Oge 2/3 EPIC-HR (Nnyocha nke Inhibition Protease maka COVID-19 na Ndị ọrịa nwere nnukwu ihe ize ndụ) enweghị usoro, ọmụmụ kpuru okpukpu abụọ. nke ndị okenye na-abụghị ụlọ ọgwụ nwere COVID-19, ndị nọ n'ihe ize ndụ dị ukwuu nke ịga n'ihu na ọrịa siri ike.Boceprevir (EBP-520) bụ HCV protease inhibitor (Ki=14 nM) maka ọgwụgwọ nke nje virus ịba ọcha n'anya C.Boceprevir nwere pegylated interferon na ribavirin (PegIFN/RBV) mere ka mmụba dị n'ọkwa nzaghachi nje na-adịgide adịgide nke ndị ọrịa nwere genotype 1 HCV.Boceprevir na-emekọrịta ihe na ọgwụgwọ immunosuppressive (IT) site na igbochi cytochrome P450 3A enzyme.